Helen Torley
CEO, President at Halozyme Therapeutics, Inc. (HALO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $46.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,300785,480 held (−0%) | $107.90 | $248K | +2.3% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,000779,480 held (−1%) | $109.33 | $656K | +1.0% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,920769,560 held (−1%) | $109.89 | $1.1M | +0.5% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 1,780767,780 held (−0%) | $110.81 | $197K | -0.4% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 8,600779,180 held (−1%) | $111.03 | $955K | -0.6% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 10,300768,880 held (−1%) | $111.84 | $1.2M | -1.3% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 900767,980 held (−0%) | $112.78 | $102K | -2.1% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 200767,780 held (−0%) | $113.69 | $23K | -2.9% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,810782,970 held (−1%) | $108.18 | $520K | +2.1% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 3,090779,880 held (−0%) | $108.91 | $337K | +1.4% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 11,900767,980 held (−2%) | $110.00 | $1.3M | +0.4% |
| Oct 8SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 200767,780 held (−0%) | $110.51 | $22K | -0.1% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 13,304774,476 held (−2%) | $107.22 | $1.4M | +3.0% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,596767,880 held (−1%) | $107.82 | $711K | +2.4% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 100767,780 held (−0%) | $108.67 | $11K | +1.6% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 14,588773,192 held (−2%) | $107.01 | $1.6M | +3.2% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,412767,780 held (−1%) | $107.58 | $582K | +2.6% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 15,492772,288 held (−2%) | $107.15 | $1.7M | +3.1% |
| Sep 11SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,508767,780 held (−1%) | $107.55 | $485K | +2.7% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 900786,880 held (−0%) | $98.96 | $89K | +11.6% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 500786,380 held (−0%) | $100.46 | $50K | +9.9% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,100784,280 held (−0%) | $101.77 | $214K | +8.5% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,000775,280 held (−1%) | $102.55 | $923K | +7.7% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 7,500767,780 held (−1%) | $103.48 | $776K | +6.7% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,703782,077 held (−1%) | $103.08 | $588K | +7.1% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,897777,180 held (−1%) | $104.11 | $510K | +6.1% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,400767,780 held (−1%) | $104.87 | $986K | +5.3% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 7,200780,580 held (−1%) | $106.36 | $766K | +3.8% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,600770,980 held (−1%) | $107.22 | $1.0M | +3.0% |
| Aug 19SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 3,200767,780 held (−0%) | $107.77 | $345K | +2.5% |
| Jul 9SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 888768,815 held (−0%) | $79.28 | $70K | +39.3% |
| Jul 9SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 1,035767,780 held (−0%) | $80.19 | $83K | +37.7% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 1,610786,170 held (−0%) | $66.39 | $107K | +66.3% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 12,989773,181 held (−2%) | $67.41 | $876K | +63.8% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,401767,780 held (−1%) | $68.35 | $369K | +61.6% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 16,600771,180 held (−2%) | $66.31 | $1.1M | +66.5% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 3,400767,780 held (−0%) | $66.75 | $227K | +65.4% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 400777,380 held (−0%) | $66.37 | $27K | +66.4% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 1,500775,880 held (−0%) | $67.68 | $102K | +63.2% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,000773,880 held (−0%) | $68.74 | $137K | +60.6% |
| Jun 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,100767,780 held (−1%) | $69.69 | $425K | +58.4% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,725778,055 held (−1%) | $64.63 | $629K | +70.8% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 3,575774,480 held (−0%) | $65.46 | $234K | +68.7% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,700767,780 held (−1%) | $66.33 | $444K | +66.5% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 100787,680 held (−0%) | $67.85 | $7K | +62.7% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 1,398786,282 held (−0%) | $70.29 | $98K | +57.1% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,802776,480 held (−1%) | $71.37 | $700K | +54.7% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,900770,580 held (−1%) | $72.15 | $426K | +53.0% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,800767,780 held (−0%) | $73.12 | $205K | +51.0% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,100775,680 held (−0%) | $68.10 | $143K | +62.1% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 3,350772,330 held (−0%) | $68.88 | $231K | +60.3% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 3,950768,380 held (−1%) | $69.79 | $276K | +58.2% |
| May 13SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 600767,780 held (−0%) | $70.81 | $42K | +55.9% |
| Apr 7SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,900771,880 held (−1%) | $63.14 | $373K | +74.9% |
| Apr 7SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,100767,780 held (−1%) | $64.02 | $262K | +72.5% |
| Apr 2SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 19,000768,780 held (−2%) | $65.36 | $1.2M | +68.9% |
| Apr 2SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 1,000767,780 held (−0%) | $65.71 | $66K | +68.0% |
| Apr 2SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 15,800771,980 held (−2%) | $64.06 | $1.0M | +72.4% |
| Apr 2SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,200767,780 held (−1%) | $64.89 | $273K | +70.2% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,100783,680 held (−1%) | $69.20 | $284K | +59.6% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 15,322768,358 held (−2%) | $69.80 | $1.1M | +58.2% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 578767,780 held (−0%) | $70.46 | $41K | +56.7% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 13,481774,299 held (−2%) | $68.85 | $928K | +60.4% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,519767,780 held (−1%) | $69.33 | $452K | +59.3% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 7,329770,451 held (−1%) | $69.94 | $513K | +57.9% |
| Mar 4SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,671767,780 held (−0%) | $70.95 | $190K | +55.6% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,551726,168 held (−0%) | $74.88 | $191K | +47.5% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,659716,509 held (−1%) | $75.94 | $734K | +45.4% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 7,790708,719 held (−1%) | $76.73 | $598K | +43.9% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 9,900718,819 held (−1%) | $76.94 | $762K | +43.5% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 10,100708,719 held (−1%) | $77.54 | $783K | +42.4% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,376713,343 held (−1%) | $78.38 | $421K | +40.9% |
| Feb 5SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,624708,719 held (−1%) | $78.94 | $365K | +39.9% |
| Dec 1SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 10,406714,882 held (−1%) | $68.51 | $713K | +61.2% |
| Dec 1SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 5,402709,480 held (−1%) | $69.44 | $375K | +59.0% |
| Dec 1SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 500708,980 held (−0%) | $70.36 | $35K | +56.9% |
| Dec 1SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 261708,719 held (−0%) | $71.60 | $19K | +54.2% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 19,900733,819 held (−3%) | $68.71 | $1.4M | +60.7% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 100733,719 held (−0%) | $69.30 | $7K | +59.3% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,500749,219 held (−1%) | $67.89 | $306K | +62.6% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 4,000745,219 held (−1%) | $68.80 | $275K | +60.5% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 11,500733,719 held (−2%) | $69.73 | $802K | +58.4% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 12,718741,001 held (−2%) | $70.22 | $893K | +57.2% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,784734,217 held (−1%) | $71.09 | $482K | +55.3% |
| Nov 12SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 498733,719 held (−0%) | $71.67 | $36K | +54.1% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 11,705742,014 held (−2%) | $75.11 | $879K | +47.0% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 8,295733,719 held (−1%) | $75.69 | $628K | +45.9% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 6,600747,119 held (−1%) | $70.51 | $465K | +56.6% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 10,200736,919 held (−1%) | $71.28 | $727K | +54.9% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,400734,519 held (−0%) | $72.07 | $173K | +53.2% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 700733,819 held (−0%) | $73.24 | $51K | +50.8% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 100733,719 held (−0%) | $74.67 | $7K | +47.9% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 14,235739,484 held (−2%) | $68.47 | $975K | +61.3% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,334737,150 held (−0%) | $69.83 | $163K | +58.1% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 2,707734,443 held (−0%) | $70.58 | $191K | +56.4% |
| Oct 3SEC | HALOHalozyme Therapeutics, Inc. | Sell Plan | 724733,719 held (−0%) | $71.67 | $52K | +54.1% |
- Sell
CEO, President Helen Torley sold $248K of HALO at $107.90 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Helen Torley sold $656K of HALO at $109.33 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Helen Torley sold $1.1M of HALO at $109.89 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Helen Torley sold $197K of HALO at $110.81 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Helen Torley sold $955K of HALO at $111.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Helen Torley sold $1.2M of HALO at $111.84 — pre-scheduled 10b5-1 plan sale.